Nexalin Technology (NXL) Price to Sales (2022 - 2026)

Nexalin Technology has reported Price to Sales for 5 years, with the latest figure at 19.9 in Q2 2026.

• On a quarterly basis, Price to Sales rose 144.42% year-over-year to 19.9 in Q2 2026; TTM through Jun 2026 was 1.11, a 66.1% decrease from a year earlier, with the FY2025 full-year figure at 1.19, down 76.37% from the prior year.
• Price to Sales was 19.9 for Q2 2026 at Nexalin Technology, up from 16.06 in the prior quarter.
• The five-year high for Price to Sales was 31.2 in Q4 2024, with the low at 0.34 in Q3 2022.
• Average Price to Sales over 5 years is 11.46, with a median of 7.17 recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Price to Sales soared 1221.03% in 2023, then sank 93.32% in 2025.
• Over 5 years, Price to Sales stood at 3.63 in 2022, then soared by 36.5% to 4.95 in 2023, then soared by 530.33% to 31.2 in 2024, then sank by 93.32% to 2.08 in 2025, then surged by 855.26% to 19.9 in 2026.
• The last three Price to Sales figures came in at 19.9 (Q2 2026), 16.06 (Q1 2026), and 2.08 (Q4 2025), per Business Quant data.